Schedule of Investments — IQ U.S. Large Cap R&D Leaders ETF

January 31, 2023 (unaudited)

	Shares		Value
Common Stocks — 99.8%
Communication Services — 15.1%
Activision Blizzard, Inc.		168	$	12,864
Alphabet, Inc., Class A*		3,029		299,386
AT&T, Inc.		837		17,049
Electronic Arts, Inc.		190		24,449
Meta Platforms, Inc., Class A*		1,602		238,650
Netflix, Inc.*		94		33,263
Pinterest, Inc., Class A*		337		8,860
Spotify Technology SA*		176		19,839
Total Communication Services				654,360
Consumer Discretionary — 13.8%
Airbnb, Inc., Class A*		167		18,555
Amazon.com, Inc.*		2,977		307,018
Aptiv PLC*		112		12,666
eBay, Inc.		329		16,286
Expedia Group, Inc.*		131		14,973
Ford Motor Co.		6,375		86,126
General Motors Co.		2,217		87,173
Rivian Automotive, Inc., Class A*		1,005		19,497
Tesla, Inc.*		203		35,164
Total Consumer Discretionary				597,458
Consumer Staples — 0.4%
Procter & Gamble Co. (The)		135		19,221
Health Care — 24.1%
Abbott Laboratories		278		30,733
AbbVie, Inc.		413		61,021
Alnylam Pharmaceuticals, Inc.*		36		8,150
Amgen, Inc.		169		42,656
Becton Dickinson and Co.		52		13,115
Biogen, Inc.*		73		21,236
Boston Scientific Corp.*		291		13,459
Bristol-Myers Squibb Co.		1,315		95,535
Danaher Corp.		69		18,242
Edwards Lifesciences Corp.*		132		10,124
Eli Lilly & Co.		202		69,518
GE HealthCare Technologies, Inc.*		119		8,273
Gilead Sciences, Inc.		641		53,806
Illumina, Inc.*		66		14,137
Incyte Corp.*		193		16,432
Johnson & Johnson		902		147,405
Medtronic PLC		355		29,710
Merck & Co., Inc.		1,190		127,818
Moderna, Inc.*		125		22,008
Novavax, Inc.*(a)		1,789		19,518
Pfizer, Inc.		2,707		119,541
Regeneron Pharmaceuticals, Inc.*		42		31,856
Seagen, Inc.*		101		14,087
Stryker Corp.		62		15,736
Thermo Fisher Scientific, Inc.		28		15,969
Vertex Pharmaceuticals, Inc.*		88		28,433
Total Health Care				1,048,518
Industrials — 5.3%
3M Co.		157		18,068
Boeing Co. (The)*		150		31,950
Caterpillar, Inc.		81		20,435
Cummins, Inc.		53		13,226
Deere & Co.		45		19,028
General Electric Co.		357		28,731
Honeywell International, Inc.		63		13,134
Lockheed Martin Corp.		32		14,824
Northrop Grumman Corp.		21		9,409
Raytheon Technologies Corp.		290		28,956
Uber Technologies, Inc.*		1,021		31,580
Total Industrials				229,341
Information Technology — 40.1%
Accenture PLC, Class A		43		11,999
Adobe, Inc.*		80		29,627
Advanced Micro Devices, Inc.*		615		46,217
Analog Devices, Inc.		92		15,775
Apple, Inc.		1,760		253,950
Applied Materials, Inc.		239		26,646
Atlassian Corp., Class A*		92		14,869
Autodesk, Inc.*		56		12,049
Block, Inc.*		307		25,088
Broadcom, Inc.		80		46,801
Cadence Design Systems, Inc.*		66		12,067
Cisco Systems, Inc.		1,455		70,815
Corning, Inc.		293		10,141
Dell Technologies, Inc., Class C		597		24,250
Dropbox, Inc., Class A*		333		7,736
Hewlett Packard Enterprise Co.		1,182		19,066
HP, Inc.		539		15,706
Intel Corp.		5,731		161,958
International Business Machines Corp.		425		57,260
Intuit, Inc.		57		24,092
Juniper Networks, Inc.		327		10,562
KLA Corp.		27		10,597
Lam Research Corp.		34		17,003
Marvell Technology, Inc.		404		17,433
Microchip Technology, Inc.		130		10,091
Micron Technology, Inc.		541		32,622
Microsoft Corp.		942		233,437
NetApp, Inc.		141		9,338
NVIDIA Corp.		374		73,068
Oracle Corp.		910		80,499
Palo Alto Networks, Inc.*		87		13,802
PayPal Holdings, Inc.*		474		38,626
QUALCOMM, Inc.		644		85,787
Salesforce, Inc.*		368		61,813
ServiceNow, Inc.*		39		17,750
Splunk, Inc.*		105		10,056
Synopsys, Inc.*		46		16,273
Texas Instruments, Inc.		86		15,240
Twilio, Inc., Class A*		194		11,609
Unity Software, Inc.*		279		9,910
VMware, Inc., Class A*		238		29,148
Western Digital Corp.*		650		28,568
Workday, Inc., Class A*		113		20,502
Total Information Technology				1,739,846
Materials — 1.0%
Corteva, Inc.		203		13,083
Dow, Inc.		174		10,327
Ginkgo Bioworks Holdings, Inc.*		10,721		20,906
Total Materials				44,316
Total Common Stocks
(Cost $4,931,182)				4,333,060

Schedule of Investments — IQ U.S. Large Cap R&D Leaders ETF (continued)

January 31, 2023 (unaudited)

	Shares		Value
Short-Term Investments — 0.4%
Money Market Funds — 0.4%
Dreyfus Government Cash Management Fund, Institutional Shares, 4.23%(b)(c)		13,211	$	13,211
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares, 4.30%(b)		3,811		3,811
Total Short-Term Investments
(Cost $17,022)				17,022
Total Investments — 100.2%
(Cost $4,948,204)				4,350,082
Other Assets and Liabilities, Net — (0.2)%				(10,226	)
Net Assets — 100.0%			$	4,339,856

				% of
Industry	Value			Net Assets
Information Technology	$	1,739,846			40.1	%
Health Care		1,048,518			24.1
Communication Services		654,360			15.1
Consumer Discretionary		597,458			13.8
Industrials		229,341			5.3
Materials		44,316			1.0
Consumer Staples		19,221			0.4
Money Market Funds		17,022			0.4
Total Investments	$	4,350,082			100.2	%
Other Assets and Liabilities, Net		(10,226	)		(0.2	)
Total Net Assets	$	4,339,856			100.0	%

*	Non-income producing securities.
(a)	All or a portion of the security was on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The aggregate market value of securities on loan was $13,223; total market value of collateral held by the Fund was $13,211.
(b)	Reflects the 1-day yield at January 31, 2023.
(c)	Represents security purchased with cash collateral received for securities on loan.

Schedule of Investments — IQ U.S. Large Cap R&D Leaders ETF (continued)

January 31, 2023 (unaudited)

The following is a summary of the inputs used to value the Fund's investments as of January 31, 2023. For more information on the valuation techniques, and their aggregation into the levels used in the table below, please refer to the Fund's most recent semi-annual or annual financial statements.

Description	Level 1		Level 2		Level 3		Total
Asset Valuation Inputs
Investments in Securities:(d)
Common Stocks	$	4,333,060	$	–	$	–	$	4,333,060
Short-Term Investments:
Money Market Funds		17,022		–		–		17,022
Total Investments in Securities	$	4,350,082	$	–	$	–	$	4,350,082

(d) For a complete listing of investments and their industries, see the Schedule of Investments.

For the period ended January 31, 2023, the Fund did not have any transfers into or out of Level 3 within the fair value hierarchy.